Search

everythinglearnresearchcommunity

for

Search:↓

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

Thai women with PCOS become more aware and change their lifestyle to manage their fertility and symptoms.

Most women with PCOS have high levels of male hormones, and free testosterone is the best marker for this.

PCOS affects many women, causing various symptoms and health risks, and is managed through lifestyle changes, medication, and support groups.

Women with PCOS are more likely to have sleep apnea, mainly if they are obese.

Testosterone replacement therapy can prevent men from fathering children and should not be used by those wanting to stay fertile.

High levels of testosterone and anti-Müllerian hormone before pregnancy are linked to a higher risk of newborns needing intensive care.

New treatments for PCOS are improving fertility and managing symptoms better.

Paternal drug exposure can harm fertility, pregnancy outcomes, and offspring health, with specific drugs linked to various reproductive issues.

Hair loss is common in women with PCOS and is linked to symptoms like acne and excess hair but not to worse metabolic health.

Finasteride use may cause sperm damage and infertility, stopping it can improve sperm health.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.

Inclusive and affirming healthcare is essential for improving transgender individuals' quality of life and health.

Women with PCOS and higher BMI, especially those with morbid obesity, are at greater risk for depression.

Free fatty acids may increase androgen production, potentially contributing to polycystic ovary syndrome.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Too much male hormone is the main cause of Polycystic Ovary Syndrome.

PNU157706 reduced rat sperm movement and fertility without affecting offspring health.

The N363S gene variant does not cause higher adrenal androgen levels in women with polycystic ovary syndrome.

Healthy diet and exercise are important for women with PCOS to manage weight and metabolic issues, and supplements like omega-3, vitamin D, and inositol may help.

Different sPLA2 enzymes affect immunity, skin and hair health, reproduction, and may be potential targets for therapy.

A man with testotoxicosis was fertile despite low FSH levels, suggesting high testosterone may allow sperm production without FSH.

Women with PCOS who had antiandrogenic treatment before pregnancy had fewer complications than those without treatment.

PCOS in lean women is a serious health condition with implications beyond fertility, affecting metabolism and increasing cardiovascular disease risk.

Low and ultralow doses of flutamide can cause liver damage in young women with high androgen levels, regardless of dose or birth control use, with higher risk for those with higher BMI and liver enzyme levels before treatment.

Teens with PCOS and a mom with PCOS have higher insulin resistance and lower adiponectin levels, which could signal early metabolic problems.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

Clinical signs of excess male hormones and actual hormone levels in the blood do not always match in women with polycystic ovary syndrome.

Women with PCOS have fewer activated T cells in their ovarian follicles, which might affect fertility.